Pharm Tech Minutes 2019.07.03: Difference between revisions

From IHE Wiki
Jump to navigation Jump to search
Michael tan (talk | contribs)
No edit summary
Simon.letellier (talk | contribs)
 
(3 intermediate revisions by one other user not shown)
Line 13: Line 13:
== Welcome ==
== Welcome ==
* Participants
* Participants
** Juergen Brandstaetter
** Stephane Spahni
** Leonidas Tzimis
** Jose Costa Teixeira
** Esther Peelen
** Marc Robberecht
** Michael van der Zel
** Michael Tan
* Review and Approve Agenda
* Review and Approve Agenda
* Review minutes previous meeting:  
* Review minutes previous meeting:  
Line 20: Line 29:
== PrePresciption ==
== PrePresciption ==
* CP  
* CP  
* Remarks from Jose Costa Teixeira. Jose will distribute the comments.
* Stephane has to make sentences clear. Will be picked up this week.
* there are also comments from Juergen from June 5th, but these have already been addressed by Stephane.
* Important to distinguish 2 types of pre-prescriptions:
** the preprescriptions of which the patient has already the medication in possession.
** the preprescription which still has to be dispensed.
* This has to clear in the find prescription list. The pharmacy does not have to see the prescription that has already be dispensed.
* A dispense quantity of prepresction cannot be changed, because the medication has already been dispensed. Only validate or decline.
* Can dosage can be? A change implies an approval of the preprescription.
* What to do with the dispense of which the preprescription has been declined.
* Stephane will add a note that the prescriber has to be careful, that the medication has already been dispensed.
* This might evolve in time.
* Stephane will adjust the document.
* We will discuss this document at the F2F.


== Webinar ==
== Webinar ==
* Presentation on 12th July
* Presentation on 12th July
* The webinar is only 40 minutes.
* We need some update. We used Juergen's version and extended the presentation
* Michael will send the slide deck to Stephane and Juergen


== Comments on MMA UBP ==
* the constraints on the resources were not clear enough.
* Marc will look at the document and approach Juergen if it is not clear.
* Reserve some time in Sardinia.
Why is UBP not used? Make the document more about the meta data and it more usable for general.


== Commenta on MMA UBP ==
* Esther will review the document and come with suggestions.




Line 35: Line 73:
[[Pharmacy Technical Committee]]
[[Pharmacy Technical Committee]]


[[Category: Agenda]]
[[Category: Minutes]]

Latest revision as of 10:45, 18 November 2019

Meeting minutes

Webex link
https://meetings.webex.com/collabs/meetings/join?uuid=M505PQOLC7KUKZL09KLV0HS44G-4VUT
WebEx Online
Meetingnumber : 237 996 823



Welcome

  • Participants
    • Juergen Brandstaetter
    • Stephane Spahni
    • Leonidas Tzimis
    • Jose Costa Teixeira
    • Esther Peelen
    • Marc Robberecht
    • Michael van der Zel
    • Michael Tan
  • Review and Approve Agenda
  • Review minutes previous meeting:

https://wiki.ihe.net/index.php/Pharm_Tech_Minutes_2019.06.05


PrePresciption

  • CP
  • Remarks from Jose Costa Teixeira. Jose will distribute the comments.
  • Stephane has to make sentences clear. Will be picked up this week.
  • there are also comments from Juergen from June 5th, but these have already been addressed by Stephane.
  • Important to distinguish 2 types of pre-prescriptions:
    • the preprescriptions of which the patient has already the medication in possession.
    • the preprescription which still has to be dispensed.
  • This has to clear in the find prescription list. The pharmacy does not have to see the prescription that has already be dispensed.
  • A dispense quantity of prepresction cannot be changed, because the medication has already been dispensed. Only validate or decline.
  • Can dosage can be? A change implies an approval of the preprescription.
  • What to do with the dispense of which the preprescription has been declined.
  • Stephane will add a note that the prescriber has to be careful, that the medication has already been dispensed.
  • This might evolve in time.
  • Stephane will adjust the document.
  • We will discuss this document at the F2F.



Webinar

  • Presentation on 12th July
  • The webinar is only 40 minutes.
  • We need some update. We used Juergen's version and extended the presentation
  • Michael will send the slide deck to Stephane and Juergen


Comments on MMA UBP

  • the constraints on the resources were not clear enough.
  • Marc will look at the document and approach Juergen if it is not clear.
  • Reserve some time in Sardinia.

Why is UBP not used? Make the document more about the meta data and it more usable for general.

  • Esther will review the document and come with suggestions.


Any other business

  • None


Pharmacy Technical Committee